Insulet Corp. Downgraded to Market Perform at JMP Securities (PODD)
Insulet Corp. (NASDAQ:PODD) was downgraded by investment analysts at JMP Securities from an “outperform” rating to a “market perform” rating in a note issued to investors on Friday, TheFlyOnTheWall.com reports.
Insulet Corp. (NASDAQ:PODD) opened at 37.75 on Friday. Insulet Corp. has a one year low of $18.50 and a one year high of $37.96. The stock has a 50-day moving average of $33.9 and a 200-day moving average of $29.77. The company’s market cap is $2.054 billion.
Insulet Corp. (NASDAQ:PODD) last released its earnings data on Wednesday, August 7th. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by $0.01. The company had revenue of $60.09 million for the quarter, compared to the consensus estimate of $60.47 million. During the same quarter in the previous year, the company posted ($0.30) earnings per share. The company’s revenue for the quarter was up 17.7% on a year-over-year basis. Analysts expect that Insulet Corp. will post $-0.63 EPS for the current fiscal year.
A number of other firms have also recently commented on PODD. Analysts at Jefferies Group raised their price target on shares of Insulet Corp. (NASDAQ:PODD) from $29.00 to $38.00 in a research note to investors on Friday, August 9th. Separately, analysts at Canaccord Genuity raised their price target on shares of Insulet Corp. (NASDAQ:PODD) from $37.00 to $40.00 in a research note to investors on Thursday, August 8th. They now have a “buy” rating on the stock. Finally, analysts at Northland Capital Partners downgraded shares of Insulet Corp. (NASDAQ:PODD) from a “market perform” rating to an “under perform” rating in a research note to investors on Thursday, July 18th. They now have a $28.00 price target on the stock.
One analyst has rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $30.58.
Insulet Corporation is primarily engaged in the development, manufacturing and sale of its OmniPod Insulin Management System (NASDAQ:PODD).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.